GH Research Plc (GHRS)
28.09
-0.24
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
28.09
0.00 (0.00%)
After-Hours: 20:00
GH Research Shareholders Equity (Quarterly) : 359.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 359.49M |
| March 31, 2026 | 263.38M |
| December 31, 2025 | 279.70M |
| September 30, 2025 | 291.40M |
| June 30, 2025 | 303.18M |
| March 31, 2025 | 310.21M |
| December 31, 2024 | 178.95M |
| September 30, 2024 | 189.37M |
| June 30, 2024 | 198.68M |
| March 31, 2024 | 209.75M |
| December 31, 2023 | 218.97M |
| Date | Value |
|---|---|
| September 30, 2023 | 225.77M |
| June 30, 2023 | 232.98M |
| March 31, 2023 | 241.83M |
| December 31, 2022 | 249.82M |
| September 30, 2022 | 256.74M |
| June 30, 2022 | 263.22M |
| March 31, 2022 | 269.48M |
| December 31, 2021 | 277.18M |
| September 30, 2021 | 283.60M |
| June 30, 2021 | 288.23M |
| March 31, 2021 | 4.315M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Atai Beckley, Inc. | 176.37M |
| Avadel Pharmaceuticals Plc | 98.22M |
| Jazz Pharmaceuticals Plc | 4.802B |
| Eli Lilly & Co. | 33.88B |
| Perrigo Co. Plc | 2.516B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.35M |
| Total Liabilities (Quarterly) | 12.86M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 28.70 |
| Net Debt Paydown Yield | 0.00% |